Abbott receives EU clearance for Advanced Medical Optics acquisition
This article was originally published in Scrip
Executive Summary
Abbott has received clearance from the European Commission for its $1.36 billion acquisition of Advanced Medical Optics (AMO) through a cash tender offer for the company's outstanding common stock. Abbott commenced the $22 per share cash tender offer on January 27th and the bid is scheduled to expire at midnight Eastern time on February 24th.